Hemab Therapeutics Holdings, Inc. (COAG): SCHEDULE 13G filed Aug 14, 2026

Name: Hemab Therapeutics Holdings, Inc. SCHEDULE 13G (0000902664-26-003462)
Creator: Hemab Therapeutics Holdings, Inc.
Published: 2026-08-14

Form type: SCHEDULE 13G
Filing date: Aug 14, 2026
Accession number: 0000902664-26-003462
Filer: Hemab Therapeutics Holdings, Inc. (CIK 2114044)